Second Generation Cardiac Cell Therapy: Combining Cardiac Stem Cells and Circulating Angiogenic Cells for the Treatment of Ischemic Heart Disease

Second Generation Cardiac Cell Therapy: Combining Cardiac Stem Cells and Circulating Angiogenic Cells for the Treatment of Ischemic Heart Disease

Show other versions (1)

Blood-derived circulatory angiogenic cells (CACs) and resident cardiac stem cells (CSCs) have both been shown to improve cardiac function after myocardial infarction (MI) but the superiority of either cell type has long been an area of speculation with no definitive head-to-head trial. In this stud...

Full description

Bibliographic Details
Main Author: Latham, Nicholas
Language:en
Published: 2013
Subjects:
heart failure
myocardial infarction
blood cells
stem cells
Online Access:http://hdl.handle.net/10393/24293

Internet

http://hdl.handle.net/10393/24293

Similar Items